Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.51 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.51 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | PARP1 | P09874 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | PRNP | P04156 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31095920 | 0.98 | PDE4A (0.50) | PDE4APDE4BPDE4CPDE4DL3MBTL1 | |
| SCHEMBL27869175 | 0.98 | PDE4A (0.50) | PDE4APDE4BPDE4CPDE4DL3MBTL1 | |
| SCHEMBL31095909 | 0.93 | PDE4A (0.47) | PDE4APDE4BPDE4CPDE4DL3MBTL1 | |
| SCHEMBL17969622 | 0.88 | PDE4A (0.48) | PDE4APDE4BPDE4CPDE4DL3MBTL1 | |
| SCHEMBL4022352 | 0.81 | SMN1; SMN2 (0.48) | PDE4APDE4BPDE4CPDE4DPARP1 | |
| SCHEMBL29678942 | 0.81 | SMN1; SMN2 (0.48) | PDE4APDE4BPDE4CPDE4DPARP1 | |
| SCHEMBL9740120 | 0.79 | MAPT (0.43) | PDE4APDE4BPDE4CPDE4DL3MBTL1 | |
| SCHEMBL10829012 | 0.75 | PARP1 (0.47) | L3MBTL1NPC1HSP90AA1PARP1ALDH1A1 | |
| SCHEMBL29849953 | 0.75 | HSP90AA1 (0.67) | L3MBTL1NPC1HSP90AA1PARP1ALDH1A1 | |
| SCHEMBL4009364 | 0.75 | HSP90AA1 (0.67) | L3MBTL1NPC1HSP90AA1PARP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250375511-A1 | METHOD FOR TREATING CONDITIONS ASSOCIATED WITH HYPERPROLIFERATING CELLS COMPRISING COMBINED ADMINISTRATION OF INFECTIOUS AGENTS AND METAL CATIONS | THERALASE TECH INC (CA) | 2025-12-11 | — | — | US | claimed |
| US-20250375458-A1 | COMPOSITIONS AND METHODS TO COMBAT MULTIDRUG-RESISTANT AND PERSISTENT T-CELL-MEDIATED, ONCOLOGICAL AND INFECTIOUS DISEASES | THERALASE TECH INC (CA) | 2025-12-11 | — | — | US | claimed |
| US-20250114456-A1 | ENHANCED IMMUNOTHERAPEUTIC METHOD COMPRISING COMBINED ADMINISTRATION OF PHOTODYNAMIC / RADIOTHERAPEUTIC COMPOUNDS AND IMMUNOTHERAPEUTIC AGENTS | THERALASE TECHNOLOGIES, INC. (CA) | 2025-04-10 | — | — | US | claimed |
| CN-110256501-B | Liver cancer cell inhibitor and preparation method thereof | 玉林师范学院 | 2024-09-10 | — | — | CN | claimed |
| US-11697707-B2 | Chemical sensors based on carbon nanotubes functionalised by conjugated polymers for analysis in aqueous medium | ECOLE POLYTECHNIQUE (FR) | 2023-07-11 | — | — | US | claimed |
| CN-115835742-A | High-quality tin-based perovskite thin film, preparation method thereof and photoelectric device | 华中科技大学 | 2023-03-21 | — | — | CN | claimed |
| CN-113105640-B | Europium coordination polymer capable of emitting red fluorescence under excitation of near-visible light, and preparation method and application thereof | 首都师范大学 | 2022-05-20 | — | — | CN | claimed |
| EP-2976347-B1 | METAL-BASED COORDINATION COMPLEXES AS PHOTODYNAMIC COMPOUNDS AND THEIR USE | MCFARLAND SHERRI ANN (US) | 2022-01-19 | — | — | EP | claimed |
| US-20210130540-A1 | CHEMICAL SENSORS BASED ON CARBON NANOTUBES FUNCTIONALISED BY CONJUGATED POLYMERS FOR ANALYSIS IN AQUEOUS MEDIUM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2021-05-06 | — | — | US | claimed |
| US-10766915-B2 | Metal-based coordination complexes as photodynamic compounds and their use | MCFARLAND SHERRI ANN (CA) | 2020-09-08 | — | — | US | claimed |
| EP-3609881-A1 | CHEMICAL SENSORS BASED ON CARBON NANOTUBES FUNCTIONALISED BY CONJUGATED POLYMERS FOR ANALYSIS IN AQUEOUS MEDIUM | Ecole Polytechnique (FR) | 2020-02-19 | — | — | EP | claimed |
| US-10115908-B2 | Imidazole[4,5-F][1,10]phenanthroline derivatives, method of preparing the same, and use thereof | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2018-10-30 | — | — | US | claimed |
| WO-2018189479-A1 | CHEMICAL SENSORS BASED ON CARBON NANOTUBES FUNCTIONALISED BY CONJUGATED POLYMERS FOR ANALYSIS IN AQUEOUS MEDIUM | ECOLE POLYTECHNIQUE (FR) | 2018-10-18 | — | — | WO | claimed |
| EP-3053922-B1 | IMIDAZOLE [4,5-F][1,10]PHENANTHROLINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | BOE TECHNOLOGY GROUP CO LTD (CN) | 2018-05-09 | — | — | EP | claimed |
| EP-3053922-A1 | IMIDAZOLE [4,5-F][1,10]PHENANTHROLINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | BOE Technology Group Co., Ltd. (CN) | 2016-08-10 | — | — | EP | claimed |
| US-20150263295-A1 | IMIDAZOLE[4,5-F][1,10]PHENANTHROLINE DERIVATIVES, METHOD OF PREPARING THE SAME, AND USE THEREOF | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2015-09-17 | — | — | US | claimed |
| US-7989089-B2 | 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) | LG DISPLAY CO., LTD. (KR) | 2011-08-02 | — | — | US | claimed |
| US-12545794-B2 | Security feature, printing ink, document of value, and manufacturing method | GIESECKE+DEVRIENT CURRENCY TECHNOLOGY GMBH (DE) | 2026-02-10 | — | — | US | disclosed |
| CN-102617617-A | Imidazo[4,5-f]1,10-phenanthroline cerium complex and preparation method thereof | UNIV SHENYANG CHEMICAL TECH | 2012-08-01 | — | — | CN | disclosed |
| WO-2010102393-A1 | 2-INDOLYL IMIDAZO [4,5-D]PHENANTHROLINE DERIVATIVES AND THEIR USE TO INHIBIT ANGIOGENESIS | LORUS THERAPEUTICS INC. (CA) | 2010-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375458-A1 | COMPOSITIONS AND METHODS TO COMBAT MULTIDRUG-RESISTANT AND PERSISTENT T-CELL-MEDIATED, ONCOLOGICAL AND INFECTIOUS DISEASES | CD4, TPMT, SLC11A2 | PDE4A 1602/4885PDE4B 1151/4885PDE4C 1981/4885 |
| US-12545794-B2 | Security feature, printing ink, document of value, and manufacturing method | MRPL9, MRPL19, MRPS9 | PDE4A 3612/4885PDE4B 3576/4885PDE4C 3639/4885 |
| US-20150263295-A1 | IMIDAZOLE[4,5-F][1,10]PHENANTHROLINE DERIVATIVES, METHOD OF PREPARING THE SAME, AND USE THEREOF | PAH, AHR, H1-5 | PDE4A 4446/4885PDE4B 4397/4885PDE4C 4601/4885 |
| US-10766915-B2 | Metal-based coordination complexes as photodynamic compounds and their use | PIN1, PPIF, PPOX | PDE4A 3304/4885PDE4B 3734/4885PDE4C 3183/4885 |
| US-20250114456-A1 | ENHANCED IMMUNOTHERAPEUTIC METHOD COMPRISING COMBINED ADMINISTRATION OF PHOTODYNAMIC / RADIOTHERAPEUTIC COMPOUNDS AND IMMUNOTHERAPEUTIC AGENTS | PDCD1, CD47, CD274 | PDE4A 3768/4885PDE4B 3473/4885PDE4C 3784/4885 |
| US-10115908-B2 | Imidazole[4,5-F][1,10]phenanthroline derivatives, method of preparing the same, and use thereof | PAH, AHR, H1-5 | PDE4A 4446/4885PDE4B 4397/4885PDE4C 4601/4885 |
| US-20250375511-A1 | METHOD FOR TREATING CONDITIONS ASSOCIATED WITH HYPERPROLIFERATING CELLS COMPRISING COMBINED ADMINISTRATION OF INFECTIOUS AGENTS AND METAL CATIONS | NFATC1, PCNA, PHPT1 | PDE4A 3346/4885PDE4B 3404/4885PDE4C 3099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.